Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses.
Ontology highlight
ABSTRACT: There is considerable interest in the use of adeno-associated virus serotype 9 (AAV9) for neurological gene therapy partly because of its ability to cross the blood-brain barrier to transduce astrocytes and neurons. This raises the possibility that AAV9 might also transduce antigen-presenting cells (APC) in the brain and provoke an adaptive immune response. We tested this hypothesis by infusing AAV9 vectors encoding foreign antigens, namely human aromatic L-amino acid decarboxylase (hAADC) and green fluorescent protein (GFP), into rat brain parenchyma. Over ensuing weeks, both vectors elicited a prominent inflammation in transduced brain regions associated with upregulation of MHC II in glia and associated lymphocytic infiltration. Transduction of either thalamus or striatum with AAV9-hAAD
SUBMITTER: Ciesielska A
PROVIDER: S-EPMC3538301 | biostudies-literature | 2013 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA